FDA Investigator Siobhan A Gallagher
Siobhan A Gallagher has conducted inspections on 135 sites in 4 countries as of 19 Feb 2020. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
135
Last Inspection Date:
19 Feb 2020
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Indonesia,
United States of America,
Korea (Republic of),
Brazil
FDA Investigators that have inspected at least one site in common with Siobhan A Gallagher:
Abigail A Andersen,
Adam S Freeman,
Alejandro Rodriguez,
Alexis R Ajello,
Alice A Blair,
Alison A Nicoli,
Alla Dubrovsky,
Amanda N Schaupp,
Ana Djurdjevic,
Andrea J Schmidt,
Andrew Tadros,
Angel K Sandhu,
Angela D Wise,
Anna L Viveros Hernandez,
Annie H Lam,
Ashar P Parikh,
Belinda E Clifton,
Bradley J Maunder,
Brandon K Lawson,
Breena L D'ambrogi,
Brenda Chavez,
Brian R Henderson,
Bruce D Broidy,
Bryan A Galvez,
Capri R Woolridge,
Carl Lee,
Cathleen A Carr Sharpe,
Celena Ngo,
Celeste K Wong,
Cheryl D Mccall,
Chloe Anne Leong,
Christine L Williams,
Chyla T Hunter,
Ciara J Bajulai Austin,
Courtney R Bolton,
Damon A Growl,
Daniel C Geffin,
Daniel J Roberts,
Daniel Velasquez,
Darla R Bracy,
David A Lum,
David G Eng,
David H Hsu,
David P Rice, Jr,
Davis,
Deborah K Richardson,
Deborah W Hsu,
Debra J Fracassa,
Devon M Shoop,
Diyo R Rai,
Douglas J Snyder,
Dustin R Abaonza,
Edith M Gonzalez,
Edna J Hidalgo,
Elaine S Chow,
Elisabeth A Drevet,
Elodie X Tong Lin,
Emal Wahab,
Emmanuel O Kerry,
Eric J Heinze,
Erica R Mahone,
Erica R Pomeroy,
Erica R Woody,
Felicia M Orlando,
Frank P Bianco,
Gam S Zamil,
Gary C Pecic, Jr,
Geraldine M Peregrin,
Gianine E Delade,
Gianine E Tompkins,
Glen E Harelson,
Greg K Keshishyan,
Haroon Vohra (NMI),
Helen J Hamaoka,
Huy T Pham,
Jackson Y See,
Jacob W Reynolds,
James C Lee, PharmD,
James P Stallings,
Janete A Oliveira,
Janice R Small,
Janice Wai,
Jeanmaire Hryshko,
Jeanne A Young,
Jeff M Uriarte,
Jennifer A Robinson,
Jennifer Crumb,
Jennifer L Johnson,
Jennifer M Pouget,
Jennifer S King,
Jessica B Clark,
Jessica B Darneille,
Joan T Briones,
Joanne M Fukuda,
Jocelyn T Ramos,
John A Daubenspeck,
John A Gonzalez,
John A Liu,
Jolene S Hedgecock,
Juan A Morales,
Jude C Dikes,
Judy C Nepsa,
Juliane Kjung Lau,
Kacie M Crowther,
Karen D Phung,
Karla J Gibler,
Kathleen S Tormey,
Kathryn M Mogen,
Kawshalya Pathiraja,
Keren Arkin,
Kevin P Foley,
Kevin T Gerrity,
Kristi B Panzer,
Krystina M Jackson,
Larisa E Pavlick,
Larkin R Buckalew,
Laura B Kennedy,
Laura L Van Wagenen,
Lauren E Sexton,
LCDR Jennifer H Rhyu,
Ligia M Cline,
Lija V Fellows,
Lilly O Barton,
Linda M Cheny,
Linda S Shook,
Lorraine N Williams,
Lourdes Andujar,
Lucila B Nwatu,
Luis A Solorzano,
Mabel M Lee,
Macropolk,
Maida Henesian (NMI),
Manuel A Moreno,
Maridali Deleon Torres,
Marissa J Chan,
Mark I Nakano,
Martina E Lagrange,
Mary C Acton,
Matthew J Hansen,
Matthew R Dionne,
Mcgrewp,
Meaghan M Rabideau,
Megan E Kulas,
Melody M Ragasa Leong,
Melvin Dorin,
Michael C Nausin,
Michael D Garcia,
Michelle L Tripp,
Natalie J Ayoub,
Neal D Singletary, PhD,
Nicole Yuen,
Nympha V Florendo,
Oluwaseyi Ojinni,
Patricia A Maestas,
Patricia P Wrona,
Paula E Davis Debella,
Peter E Baker,
Phung,
Quynh H Strandberg,
Randall J Plunkett,
Randall P Zielinski,
Raymond Souweha,
Richard W Tubb,
Riley C Graham,
Roberta K Smith,
Rochelle A Rolnik,
Romero,
Ronald P Boyce,
Rumany C Penn, PharmD,
Samantha E Rafferty,
Sandra S Saniga,
Sara M Richardson,
Sarah A Hassas,
Savannah E Samp,
Sean P Desbrow,
Seema S Singh,
Sergio Chavez (NMI),
Sharon L Shane,
Shererk,
Siobhan G Taylor,
Sondra R Davis,
Steve P Yost,
Steven B Chiu,
Steven J Branch,
Steven M Galvez,
Stuart W Russell,
Suzanne M Crotty,
Tanya E Malais,
Teresa Lee,
Terrence Gee,
Thai T Duong,
Thao T Kwan,
Thomas N Adjabeng,
Thomas W Gordon,
Timothy C Grome,
Travelle D Mason,
Uduak M Inokon,
Victoria L Morgan,
Wen Jun Peng,
William J Foust,
William J Weis
Siobhan A Gallagher's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| April, 2019 | FDA 483 | Global Vitality Inc. - Form 483, 2019-04-24 |
| April, 2018 | FDA 483 | Traditional Medicinals, Inc - Form 483, 2018-04-12 |
| April, 2017 | FDA 483 | Shunny Corporation dba Sampac Enterprise - Form 483, 2017-04-11 |
| August, 2015 | EIR | Food Service Partners Inc - EIR, 2015-08-06 |
| October, 2017 | FDA 483 | Golden Gate Soy Products, Inc. - Form 483, 2017-10-05 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more